199 related articles for article (PubMed ID: 9129235)
41. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227
[TBL] [Abstract][Full Text] [Related]
42. Elastin Modification by 4-Hydroxynonenal in Hairless Mice Exposed to UV-A. Role in Photoaging and Actinic Elastosis.
Larroque-Cardoso P; Camaré C; Nadal-Wollbold F; Grazide MH; Pucelle M; Garoby-Salom S; Bogdanowicz P; Josse G; Schmitt AM; Uchida K; Zarkovic K; Salvayre R; Nègre-Salvayre A
J Invest Dermatol; 2015 Jul; 135(7):1873-1881. PubMed ID: 25739050
[TBL] [Abstract][Full Text] [Related]
43. Amyloid beta 2-microglobulin is modified with N epsilon-(carboxymethyl)lysine in dialysis-related amyloidosis.
Niwa T; Sato M; Katsuzaki T; Tomoo T; Miyazaki T; Tatemichi N; Takei Y; Kondo T
Kidney Int; 1996 Oct; 50(4):1303-9. PubMed ID: 8887292
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical study of chronological and photo-induced aging skins using the antibody raised against D-aspartyl residue-containing peptide.
Miura Y; Fujimoto N; Komatsu T; Tajima S; Kawada A; Saito T; Fujii N
J Cutan Pathol; 2004 Jan; 31(1):51-6. PubMed ID: 14675285
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemical detection of imidazolone and N(epsilon)-(carboxymethyl)lysine in aortas of hemodialysis patients.
Takayama F; Aoyama I; Tsukushi S; Miyazaki T; Miyazaki S; Morita T; Hirasawa Y; Shimokata K; Niwa T
Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1101-9. PubMed ID: 9846892
[TBL] [Abstract][Full Text] [Related]
46. An immunochemical study on tau glycation in paired helical filaments.
Ko LW; Ko EC; Nacharaju P; Liu WK; Chang E; Kenessey A; Yen SH
Brain Res; 1999 Jun; 830(2):301-13. PubMed ID: 10366687
[TBL] [Abstract][Full Text] [Related]
47. Immunochemical approaches to AGE-structures: characterization of anti-AGE antibodies.
Ikeda K; Nagai R; Sakamoto T; Sano H; Araki T; Sakata N; Nakayama H; Yoshida M; Ueda S; Horiuchi S
J Immunol Methods; 1998 Jun; 215(1-2):95-104. PubMed ID: 9744751
[TBL] [Abstract][Full Text] [Related]
48. Antibodies against advanced glycation end product Nepsilon-(carboxymethyl)lysine in healthy controls and diabetic patients.
Vay D; Vidali M; Allochis G; Cusaro C; Rolla R; Mottaran E; Bellomo G; Albano E
Diabetologia; 2000 Nov; 43(11):1385-8. PubMed ID: 11126407
[TBL] [Abstract][Full Text] [Related]
49. Immunological evidence that non-carboxymethyllysine advanced glycation end-products are produced from short chain sugars and dicarbonyl compounds in vivo.
Takeuchi M; Makita Z; Bucala R; Suzuki T; Koike T; Kameda Y
Mol Med; 2000 Feb; 6(2):114-25. PubMed ID: 10859028
[TBL] [Abstract][Full Text] [Related]
50. Maillard reactions by alpha-oxoaldehydes: detection of glyoxal-modified proteins.
Sady C; Jiang CL; Chellan P; Madhun Z; Duve Y; Glomb MA; Nagaraj RH
Biochim Biophys Acta; 2000 Sep; 1481(2):255-64. PubMed ID: 11018716
[TBL] [Abstract][Full Text] [Related]
51. A quantitative model of the generation of N(epsilon)-(carboxymethyl)lysine in the Maillard reaction between collagen and glucose.
Ferreira AE; Ponces Freire AM; Voit EO
Biochem J; 2003 Nov; 376(Pt 1):109-21. PubMed ID: 12911334
[TBL] [Abstract][Full Text] [Related]
52. Membrane proteins of human erythrocytes are modified by advanced glycation end products during aging in the circulation.
Ando K; Beppu M; Kikugawa K; Nagai R; Horiuchi S
Biochem Biophys Res Commun; 1999 Apr; 258(1):123-7. PubMed ID: 10222246
[TBL] [Abstract][Full Text] [Related]
53. Prediction of CML contents in the Maillard reaction products for casein-monosaccharides model.
Oh MJ; Kim Y; Hoon Lee S; Lee KW; Park HY
Food Chem; 2018 Nov; 267():271-276. PubMed ID: 29934167
[TBL] [Abstract][Full Text] [Related]
54. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins.
Ahmed MU; Brinkmann Frye E; Degenhardt TP; Thorpe SR; Baynes JW
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):565-70. PubMed ID: 9182719
[TBL] [Abstract][Full Text] [Related]
55. N epsilon-(carboxymethyl)lysine in blood from maintenance hemodialysis patients may contribute to dialysis-related amyloidosis.
Motomiya Y; Oyama N; Iwamoto H; Uchimura T; Maruyama I
Kidney Int; 1998 Oct; 54(4):1357-66. PubMed ID: 9767556
[TBL] [Abstract][Full Text] [Related]
56. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products.
Mera K; Nagai R; Haraguchi N; Fujiwara Y; Araki T; Sakata N; Otagiri M
Free Radic Res; 2007 Jun; 41(6):713-8. PubMed ID: 17516244
[TBL] [Abstract][Full Text] [Related]
57. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
58. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody.
Koito W; Araki T; Horiuchi S; Nagai R
J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494
[TBL] [Abstract][Full Text] [Related]
59. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen.
Dunn JA; McCance DR; Thorpe SR; Lyons TJ; Baynes JW
Biochemistry; 1991 Feb; 30(5):1205-10. PubMed ID: 1899338
[TBL] [Abstract][Full Text] [Related]
60. Advanced glycation end products regulate extracellular matrix protein and protease expression by human glomerular mesangial cells.
Berrou J; Tostivint I; Verrecchia F; Berthier C; Boulanger E; Mauviel A; Marti HP; Wautier MP; Wautier JL; Rondeau E; Hertig A
Int J Mol Med; 2009 Apr; 23(4):513-20. PubMed ID: 19288028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
